Data presented at San Antonio Breast Cancer Symposium® demonstrate preliminary 4-month PFS rate of 44% in ongoing Phase 2 trial in second- or ...
News
- Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in ... - BioSpace
- Texas state court throws out lawsuit against San Antonio doctor who violated abortion law
Dr. Alan Braid, abortion provider and owner of Alamo Women's Reproductive Services in San Antonio, sits in his office for a portrait on June 14, 2022.
- Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 ...
Active biotech and pharma companies in the markets this week include ... at the San Antonio Breast Cancer Symposium – Oncolytics Biotech® Chinese ...
- Duration of Prior CDK4/6 Inhibitor Treatment Tied to PFS With Elacestrant
... rates,” said Virginia Kaklamani, MD, of UT Health San Antonio, when presenting the results at the San Antonio Breast Cancer Symposium 2022.
- Baptist plans $14M hospital expansion amid multiple CEO changes - The Business Journals
Growth is driving demand for health care in the San Antonio market's southern region.